EverPro (Pea Protein Hydrolysate)

EverPro is a pea protein hydrolysate containing pre-digested amino acid chains designed for enhanced absorption. Currently, no clinical health benefits have been established from available research for this specific ingredient.

Origin & History

Pea protein hydrolysate is derived from pea (Pisum sativum) protein concentrate or isolate that undergoes enzymatic proteolysis to break down proteins into smaller peptide fragments. The production process involves proteolytic hydrolysis using enzymes such as Alcalase and Neutrase to achieve a degree of hydrolysis between 15-35%, followed by ultrafiltration and purification steps.

Historical & Cultural Context

No historical or traditional use information was provided in the research dossier. The available data focuses exclusively on modern manufacturing processes.

Health Benefits

• No clinical health benefits can be established from the available research
• The research dossier contains only manufacturing methodology information
• No human studies or clinical trials were provided in the research
• No efficacy data for muscle protein synthesis was included
• No safety or bioavailability studies were available to support health claims

How It Works

EverPro pea protein hydrolysate theoretically provides pre-digested dipeptides and tripeptides that bypass normal protein digestion through direct absorption via peptide transporters PEPT1 and PEPT2 in the small intestine. The hydrolysis process breaks down native pea proteins into smaller peptide fragments, potentially allowing faster amino acid availability compared to intact proteins. However, specific molecular pathways for this product have not been clinically validated.

Scientific Research

The research dossier provided contains no clinical trials, randomized controlled trials, or meta-analyses. No PubMed PMIDs were available in the provided research materials.

Clinical Summary

No human clinical studies have been conducted specifically on EverPro pea protein hydrolysate to establish efficacy for muscle protein synthesis or other health outcomes. The available research dossier contains only manufacturing methodology information without clinical trial data. No safety studies, bioavailability assessments, or comparative effectiveness trials were provided. The evidence base is insufficient to support specific health claims for this ingredient.

Nutritional Profile

EverPro is a pea protein hydrolysate derived from yellow peas (Pisum sativum), processed via enzymatic hydrolysis to break intact proteins into shorter peptide chains and free amino acids. As a hydrolysate, protein content is typically 80–90% on a dry weight basis, consistent with commercial pea protein hydrolysate concentrates. Amino acid profile reflects pea protein composition: rich in branched-chain amino acids (BCAAs) — leucine (~8% of total amino acids), isoleucine (~4%), and valine (~4%); high in lysine (~7%), arginine (~8–9%), and glutamic acid (~16–17%); moderately low in methionine (~1%) and tryptophan (~1%), which are the primary limiting amino acids. The hydrolysis process increases the proportion of di- and tri-peptides relative to intact protein, which generally enhances gastric emptying rate and nitrogen absorption speed compared to non-hydrolyzed pea protein isolate. Carbohydrate content is typically low (<5% dry weight) due to processing, with negligible fiber remaining after isolation. Fat content is minimal (<2% dry weight). Micronutrient content is reduced relative to whole peas but may retain trace amounts of iron (peas are a notable plant iron source), zinc, and magnesium at concentrations dependent on processing conditions. No specific micronutrient quantities for EverPro have been confirmed in the available dossier. Bioavailability is expected to be moderately high due to hydrolysis — hydrolyzed forms demonstrate faster absorption kinetics than intact proteins — however, no specific DIAAS (Digestible Indispensable Amino Acid Score) or PDCAAS data for EverPro itself was provided. General pea protein DIAAS is estimated at 0.82–0.93 relative to whole egg reference, with hydrolysis potentially improving this marginally. No data on bioactive peptide fractions, glycemic index, or specific functional peptide sequences was included in the available research dossier.

Preparation & Dosage

No clinically studied dosage ranges were available in the provided research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified in available research

Safety & Interactions

No specific safety data is available for EverPro pea protein hydrolysate from clinical studies. As a pea-derived protein, it may cause allergic reactions in individuals sensitive to legumes. Potential interactions with medications affecting amino acid metabolism are unknown due to lack of pharmacokinetic studies. Safety during pregnancy and lactation has not been established through clinical research.